Zdrowie i gospodarka · 16/12/2008

FDA Releases Draft Guidance on Bioequivalence Recommendation for Vancomycin HCl

The Food and Drug Administration (FDA) has made available a draft guidance document outlining specific recommendations for designing bioequivalence studies to support abbreviated new drug applications (ANDAs) for vancomycin HCl capsules, a key antibiotic medication.